| 1 |
32168763 | Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2. | 2020 Mar 11 |
1 |
| 2 |
28404891 | HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells. | 2017 Apr 18 |
1 |
| 3 |
29088724 | Inhibition of angiogenesis by arsenic trioxide via TSP-1-TGF-β1-CTGF-VEGF functional module in rheumatoid arthritis. | 2017 Sep 26 |
1 |
| 4 |
26276563 | Arsenic Trioxide Attenuates NF-κB and Cytokine mRNA Levels in the Livers of Cocks. | 2016 Apr |
1 |
| 5 |
25845556 | Tetraarsenic hexoxide demonstrates anticancer activity at least in part through suppression of NF-κB activity in SW620 human colon cancer cells. | 2015 Jun |
2 |
| 6 |
24627159 | Arsenic hexoxide enhances TNF-α-induced anticancer effects by inhibiting NF-κB activity at a safe dose in MCF-7 human breast cancer cells. | 2014 May |
4 |
| 7 |
22384180 | Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6. | 2012 |
1 |
| 8 |
21078271 | [Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1]. | 2010 Nov |
1 |
| 9 |
22966360 | Effect of thalidomide and arsenic trioxide on the release of tumor necrosis factor-α and vascular endothelial growth factor from the KG-1a human acute myelogenous leukemia cell line. | 2010 Jul |
5 |
| 10 |
17673311 | Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways. | 2007 Nov |
2 |
| 11 |
16920938 | Human macrophages constitute targets for immunotoxic inorganic arsenic. | 2006 Sep 1 |
1 |
| 12 |
12148893 | Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation. | 2002 May |
1 |